Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.38
▲ $2.10 (+0.83%) today
Markets open · 3:19pm ET

JNJ Coverage Page 73

6:35am ET
Investing

Short Sellers Savage Weakest Stocks

Short sellers aimed their guns at the stocks of the financially weakest companies, as data from the period that ended on September 14 shows. The actions hold true for shares that trade on…

Douglas A. McIntyre
9:05am ET
Investing

American Stocks Dominate Global Equities

More American companies are among the 20 largest in the world than at any time in the past decade. This is because earnings at U.S. companies have risen faster than the rest…

Trey Thoelcke
8:00am ET
Investing

Largest Short Interest Positions

    The short interest in the stocks with the largest positions as of August 15: Bank of America Corp. (NYSE: BAC) down 2% to 220 million shares. Nokia Corp. (NYSE: NOK) up…

Douglas A. McIntyre
10:56am ET
Health and Healthcare

Medical Device Recalls at Eight-Month High

The quarterly ExpertRECALL Index released today indicates that more than 123 million medical device units were recalled during the second quarter of 2012, an eight-quarter high. The medical device category  includes such…

Trey Thoelcke
6:46am ET
Investing

Shorts Cut Interest in Old Tech Firms

Short sellers backed away from their gambles on old tech firms as they increased their positions in new Web 2.0 companies. For the period that ended July 31, short sellers cut their…

Douglas A. McIntyre
6:34am ET
Investing

Media Digest (8/7/2012) Reuters, WSJ, NYT, FT, Bloomberg

Chesapeake Energy Corp. (NYSE: CHK) sells assets to improve earnings. (Reuters) Standard Chartered may lose its New York banking license over allegations it hid $250 billion in transactions tied to Iran. (Reuters) Acer…

Douglas A. McIntyre
5:44pm ET
Health and Healthcare

J&J, Pfizer Halt Development of Alzheimer’s Drug

Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed a…

247sam
6:29am ET
Investing

Former Avon CEO and Scandal: All Ethics Start at the Top

The Wall Street Journal reports that federal prosecutors want to speak with former Avon Products (NYSE: AVP) CEO Andrea Jung. These prosecutors continue to investigate Avon’s compliance with the Foreign Corrupt Practices…

Douglas A. McIntyre
6:17am ET
Media

Media Digest (7/20/2012) Reuters, WSJ, NYT, FT, Bloomberg

Eurozone officials set final terms for a bailout of Spain’s banks. (Reuters) Marissa Mayer will receive as much as $70 million to head Yahoo! (NASDAQ: YHOO). (Reuters) Banks hit by the Libor investigation may…

C DUK F
Douglas A. McIntyre
8:34am ET
Health and Healthcare

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted EPS of…

Paul Ausick